American Portfolios Advisors’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-135
Closed -$10.8K 3484
2021
Q1
$10.8K Sell
135
-57
-30% -$4.45K ﹤0.01% 2349
2020
Q4
$15.1K Hold
192
﹤0.01% 1944
2020
Q3
$8.44K Sell
192
-130
-40% -$6.41K ﹤0.01% 2052
2020
Q2
$14.2K Hold
322
﹤0.01% 1788
2020
Q1
$11.6K Hold
322
﹤0.01% 1746
2019
Q4
$22.8K Hold
322
﹤0.01% 1668
2019
Q3
$24.1K Hold
322
﹤0.01% 1594
2019
Q2
$26K Sell
322
-91
-22% -$6.4K ﹤0.01% 1566
2019
Q1
$27.6K Hold
413
﹤0.01% 1443
2018
Q4
$30.7K Sell
413
-408
-50% -$33.7K ﹤0.01% 1220
2018
Q3
$75.6K Sell
821
-415
-34% -$39.5K 0.01% 945
2018
Q2
$122K Buy
1,236
+591
+92% +$66.1K 0.02% 737
2018
Q1
$71.9K Sell
645
-59
-8% -$6.61K 0.01% 883
2017
Q4
$72.4K Buy
+704
New +$70.1K 0.01% 854

American Portfolios Advisors's CMD Position: Q2 2021 in Review

American Portfolios Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 135 shares — an estimated $10.8K sold.

American Portfolios Advisors first reported a position in CMD in Q4 2017 and held it in 14 quarters. The position peaked at $122K in Q2 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • American Portfolios Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 135 Cantel Medical Corporation shares in Q2 2021, an estimated $10.8K.
  • American Portfolios Advisors first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 14 quarters.
  • American Portfolios Advisors's Cantel Medical Corporation position peaked at $122K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.